Rate of misdiagnosis and clinical usefulness of the correct diagnosis in exudative neovascular maculopathy secondary to AMD versus pachychoroid disease

摘要

The aim of this study was to explore the relative prevalence and clinical differences between age-related macular degeneration (AMD) and pachychoroid disease in patients older than 50?years with newly diagnosed exudative neovascular maculopathy, and also assess the rate of misdiagnosis between these two disorders. In this retrospective observational study, we reviewed data from patients 50?years of age and older with newly diagnosed treatment-na?ve exudative macular neovascularization (MNV) secondary to AMD or pachychoroid disease. Of the 139 patients (139 eyes) who fulfilled the inclusion criteria, 35 patients were graded as being affected by pachychoroid disease complicated by exudative MNV and 104 subjects had neovascular AMD. Therefore, prevalence of pachychoroid disease complicated by exudative MNV was 25.2% (confidence interval—CI 18.2–33.2%). Mean?±?SD age was 67.0?±?8.8?years in the pachychoroid disease group and 80.6?±?6.6?years in the neovascular AMD group (P??0.0001). At baseline, BCVA was better in patients with pachychoroid disease complicated by exudative MNV (0.4?±?0.3 LogMAR vs. 0.7?±?0.5 LogMAR, P?=?0.003). At the 1-year follow-up visit, BCVA was still better in patients with pachychoroid-associated MNV (0.34?±?0.32 LogMAR vs. 0.59?±?0.52 LogMAR; P?=?0.005). In our study cohort, 19 patients were graded to be affected by pachychoroid disease complicated by exudative MNV even though a diagnosis of neovascular AMD was erroneously reported in their medical records at baseline. In conclusion, pachychoroid disease is a frequent cause of exudative MNV in aged patients with a high rate of misdiagnosis. A correct diagnosis may be important as these two disorders differ in terms of clinical characteristics and prognosis.